Glanzmann Thrombasthenia Clinical Trials

15 clinical trials for Glanzmann Thrombasthenia across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Videomicroscopy for the Prediction of Bleeding in Constitutional Haemorrhagic Diseases — RECRUITING · NA
• ATHNdataset Registry — RECRUITING
• Eptacog Beta in Glanzmann's (HeT_LFB-Strength-Study_FID531) — RECRUITING · PHASE2
• The Genetics and Functional Basis of Inherited Platelet, White Blood Cell, Red Blood Cell, and Blood Clotting Disorders. — RECRUITING
• A Phase 1/2, First-in-Human, Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Participants With Glanzmann Thrombasthenia — TERMINATED · PHASE2
• Targeting TFPI With Concizumab to Improve Haemostasis in Glanzmann Thrombasthenia Patients: an in Vitro Study — COMPLETED · NA
• Anti-αIIbβ3 Immunization in Glanzmann Thrombasthenia: Prevalence and Associated Risk Factors: Thrombasthenia Anti-αIIbβ3 Antibodies Study (TAAS) — COMPLETED · NA
• A Phase 1/2 Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Glanzmann Thrombasthenia — ACTIVE_NOT_RECRUITING · PHASE1
• Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer — TERMINATED · PHASE2
• Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies — TERMINATED · NA
• The Experiences of People Who Live With Glanzmanns Thrombasthenia. — COMPLETED
• Multinational Glanzmann Study — NOT_YET_RECRUITING
• Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Inherited Bleeding Disorders — TERMINATED · PHASE1
• Bone Marrow Transplant With Abatacept for Non-Malignant Diseases — COMPLETED · PHASE1
• Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation — TERMINATED · NA

Refine this search